Patents by Inventor Kyoungbaek CHOI

Kyoungbaek CHOI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION FOR TREATING PAIN
    Publication number: 20220362342
    Abstract: A composition useful for alleviating or treating pain and uses thereof are disclosed. The composition containing glutamate decarboxylase and a gene coding for an anti-inflammatory cytokine. A method for alleviating or treating pain of a subject includes administering the composition to the subject.
    Type: Application
    Filed: July 28, 2022
    Publication date: November 17, 2022
    Applicant: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong Kim, Heonsik Choi, Kyoungbaek Choi, Minjung Kim, Hyeonyoul Lee, Minju Kim, Daewook Kim, Min Kim, Jangjoon Park, Kyung-Ran Kim, Hyelin Ji
  • Composition for treating pain
    Patent number: 11433145
    Abstract: The present invention relates to: a composition for alleviating or treating pain, the composition comprising glutamate decarboxylase and a gene coding for an anti-inflammatory cytokine; and a method for alleviating or treating pain by using the composition.
    Type: Grant
    Filed: September 20, 2016
    Date of Patent: September 6, 2022
    Assignee: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong Kim, Heonsik Choi, Kyoungbaek Choi, Minjung Kim, Hyeonyoul Lee, Minju Kim, Daewook Kim, Min Kim, Jangjoon Park
  • Composition for treating inflammatory disease induced by hyperimmune response
    Patent number: 11191787
    Abstract: Provided is a cell therapeutic agent for treating an inflammatory disease induced by a hyperimmune response, more specifically, a composition for treating an inflammatory disease induced by a hyperimmune response, which comprises (i) a chondrocyte or a cell capable of differentiating into a chondrocyte; and (ii) a cell into which a gene encoding TGF-? is introduced, wherein the cell in (ii) is derived from human embryonic kidney 293 (HEK-293) cell.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: December 7, 2021
    Assignees: KOLON LIFE SCIENCE, INC.
    Inventors: Heonsik Choi, Kyoungbaek Choi, Hyeonyoul Lee, Daewook Kim, Hyesun Lee, Min Kim, Sujeong Kim
  • Method for delivery of biological molecule to nervous tissue
    Patent number: 10898590
    Abstract: A method for delivery of a therapeutic agent to a nervous tissue. In particular, a method of delivering a therapeutic agent to a nervous tissue protected by the brain-blood barrier or meninges is disclosed. The method for delivery allows delivery of a therapeutic agent to a nervous tissue with high efficiency. In addition, the delivery method of a therapeutic agent to a nervous tissue is safe since it has lower side effects such as nervous damage than a method of administering a therapeutic agent directly to a nervous tissue.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: January 26, 2021
    Assignee: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong Kim, Heonsik Choi, Kyoungbaek Choi, Minjung Kim, Yejin Kwon, Hyeonyoul Lee, Minju Kim, Daewook Kim, Jangjoon Park, Yeomoon Sim
  • METHOD FOR DELIVERY OF BIOLOGICAL MOLECULE TO NERVOUS TISSUE
    Publication number: 20190099504
    Abstract: A method for delivery of a therapeutic agent to a nervous tissue. In particular, a method of delivering a therapeutic agent to a nervous tissue protected by the brain-blood barrier or meninges is disclosed. The method for delivery allows delivery of a therapeutic agent to a nervous tissue with high efficiency. In addition, the delivery method of a therapeutic agent to a nervous tissue is safe since it has lower side effects such as nervous damage than a method of administering a therapeutic agent directly to a nervous tissue.
    Type: Application
    Filed: December 12, 2018
    Publication date: April 4, 2019
    Applicant: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong KIM, Heonsik CHOI, Kyoungbaek CHOI, Minjung KIM, Yejin KWON, Hyeonyoul LEE, Minju KIM, Daewook KIM, Jangjoon PARK, Yeomoon SIM
  • COMPOSITION FOR TREATING INFLAMMATORY DISEASE INDUCED BY HYPERIMMUNE RESPONSE
    Publication number: 20180264045
    Abstract: Provided is a cell therapeutic agent for treating an inflammatory disease induced by a hyperimmune response, more specifically, a composition for treating an inflammatory disease induced by a hyperimmune response, which comprises (i) a chondrocyte or a cell capable of differentiating into a chondrocyte; and (ii) a chondrocyte into which a gene encoding TGF-? is introduced or a cell capable of differentiating into a chondrocyte into which a gene encoding TGF-? is introduced.
    Type: Application
    Filed: February 5, 2016
    Publication date: September 20, 2018
    Applicant: Kolon Life Science, Inc.
    Inventors: Heonsik Choi, Kyoungbaek Choi, Hyeonyoul Lee, Daewook Kim, Hyesun Lee, Min Kim, Sujeong Kim
  • COMPOSITION FOR TREATING PAIN
    Publication number: 20180250421
    Abstract: The present invention relates to: a composition for alleviating or treating pain, the composition comprising glutamate decarboxylase and a gene coding for an anti-inflammatory cytokine; and a method for alleviating or treating pain by using the composition.
    Type: Application
    Filed: September 20, 2016
    Publication date: September 6, 2018
    Applicant: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong KIM, Heonsik CHOI, Kyoungbaek CHOI, Minjung KIM, Hyeonyoul LEE, Minju KIM, Daewook KIM, Min KIM, Jangjoon PARK